also like3 Dec 2018 17:00
the diversification opp with income streams. More M/A to come too, or maybe even a sale on the cards, lol.
'Following the success of the Yourgene Bioscience acquisition in 2017, the Group continues to consider additional selective synergistic M&A opportunities. The market is fragmented with minimal medium-sized entities, which presents an opportunity for market consolidation, especially where new products and customers can be acquired into the Group. I believe we now have a very significant opportunity ahead of us and I look forward to providing further updates on our progress'.